New smoking cessation treatment

Cytisine is a partial nicotine agonist that can help with smoking cessation. A large randomized trial found 12 month sustained quit rates were significantly higher in the cytisine group (8% vs 2%); it was well tolerated and inexpensive. Although quit rates are still disappointingly low, they are better than placebo, and the drug is well tolerated and inexpensive (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment